Postoperative Dysphagia Management in Hemifacial Spasm: A Case Report of Combined Catheter Balloon and Neuromuscular Stimulation.
Abstract
BACKGROUND Hemifacial spasm is a frequently encountered cranial nerve disorder caused by vascular compression, and microvascular decompression is considered the criterion standard treatment, particularly for cases resistant to pharmacological or botulinum toxin therapy. Although microvascular decompression is generally safe, it carries the risk of cranial nerve complications. Glossopharyngeal and vagus nerve dysfunction can result in cricopharyngeal dysfunction, leading to significant postoperative dysphagia characterized by poor upper esophageal sphincter (UES) opening, aspiration, and pharyngeal residue. Early and effective rehabilitation is critical but rarely documented in such cases. CASE REPORT We present a case of a 58-year-old man who developed severe dysphagia following microvascular decompression for left-sided hemifacial spasm. Postoperative videofluoroscopic swallowing study (VFSS) confirmed cricopharyngeal dysfunction, showing delayed hyoid elevation and restricted UES opening. A comprehensive rehabilitation protocol was initiated, combining neuromuscular electrical stimulation (NMES) with balloon-guided volitional swallowing training (CBD). NMES targeted submental and laryngeal regions to facilitate muscle activation and enhance sensory feedback. CBD involved repeated, guided swallowing with balloon catheter assistance to promote UES opening. After 2 weeks of daily therapy, VFSS showed significant improvement in UES relaxation and pharyngeal clearance. The patient transitioned from nasogastric feeding to full oral intake, with a functional oral intake scale score of 6. CONCLUSIONS Cricopharyngeal dysfunction is a rare but disabling complication following microvascular decompression. This case demonstrates that early, combined rehabilitative approaches - especially integration of NMES and volitional CBD - can lead to meaningful recovery of swallowing function and better patient outcomes.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | microvascular
|
미세수술 | dict | 4 | |
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | Neuromuscular
|
scispacy | 1 | ||
| 해부 | Glossopharyngeal
|
scispacy | 1 | ||
| 해부 | pharyngeal
|
scispacy | 1 | ||
| 해부 | laryngeal
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | oral
|
scispacy | 1 | ||
| 합병증 | esophageal sphincter
|
scispacy | 1 | ||
| 합병증 | neuromuscular electrical
|
scispacy | 1 | ||
| 합병증 | pharyngeal
|
scispacy | 1 | ||
| 합병증 | nasogastric
|
scispacy | 1 | ||
| 약물 | CBD
|
C0006863
cannabidiol
|
scispacy | 1 | |
| 약물 | NMES
→ neuromuscular electrical stimulation
|
scispacy | 1 | ||
| 질환 | Postoperative Dysphagia
|
scispacy | 1 | ||
| 질환 | Hemifacial Spasm
|
C0278152
Hemifacial Spasm
|
scispacy | 1 | |
| 질환 | cranial nerve disorder
|
C0010266
Cranial nerve diseases
|
scispacy | 1 | |
| 질환 | cranial nerve complications
|
scispacy | 1 | ||
| 질환 | upper esophageal sphincter
|
C1451819
Upper Esophageal Sphincter
|
scispacy | 1 | |
| 질환 | dysphagia
|
C0011168
Deglutition Disorders
|
scispacy | 1 | |
| 질환 | left-sided hemifacial spasm
|
scispacy | 1 | ||
| 질환 | CBD
|
scispacy | 1 | ||
| 기타 | cranial nerve
|
scispacy | 1 | ||
| 기타 | vascular
|
scispacy | 1 | ||
| 기타 | vagus nerve
|
scispacy | 1 | ||
| 기타 | man
|
scispacy | 1 | ||
| 기타 | hyoid
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
MeSH Terms
Humans; Male; Deglutition Disorders; Middle Aged; Hemifacial Spasm; Postoperative Complications; Electric Stimulation Therapy; Microvascular Decompression Surgery
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.